The American Diabetes Association is putting out an expanded third edition of their helpful book The Uncomplicated Guide to Diabetes Complications. In addition to advice...

Puzzled by the recent FDA decisions? Dr. Sanjay Kaul discusses the regulatory environment for diabetes and obesity medications.

Dan Hurley gives a passionate assessment of the rise of diabetes in his book, Diabetes Rising .

Kelly muses on the search for a cure, and what we have in the meantime.

Tackling diabetes requires all the help you can get – see Dana Lewis's thoughts on Fit4D’s Personalized Diabetes Coaching here.

People with diabetes are at significantly increased risk for kidney impairment or kidney failure. Kidney disease can complicate the treatment of type 2 diabetes because...

A girl can dream, right? (...of cures and new insulins...)

We recently reviewed three drug candidates for the treatment of obesity – Contrave, lorcaserin, and Qnexa. All three drugs in development: they all have been submitted...

Academy Award winner Olympia Dukakis and her husband Louis Zorich are campaigning to increase diabetes awareness. While 18 million people are currently diagnosed with...

On January 27, the Food and Drug Administration (FDA) granted approval to Bydureon, a new drug for type 2 diabetes that is injected once a week. Approved last year in...

In late November, the Centers for Medicare and Medicaid Services (the federal agency that administers the two public insurance programs) announced that Medicare would...

diaTribe 's take on the recent New England Journal of Medicine's piece on weight gain - and loss!

We had the privilege of attending the inaugural Partnership for a Healthier America (PHA) Building a Healthier Future Summit in late 2011 in Washington, DC, where we...

Want faster acting insulin? CDE Gary Scheiner shows you some options with five innovative tips that you may want to consider…

The Diabetes Barometer

We love articles with information that you can apply to your own life. In this article, you receive guidance on how to lower your risk of cardiovascular disease, the...

The Obesity Society's annual meeting has long been our favorite place to catch up on the basic science research behind this critical problem.

In October, Novo Nordisk announced that it had submitted its two new “next-generation” insulin products for approval in both the US and Europe (and Japan to follow soon...

Eye diseases leading to blindness are consistently ranked among the greatest fears of people with diabetes, and the most common of these eye diseases is called diabetic...

Exercise and weight loss have been shown to significantly reduce a person’s risk of moving from prediabetes to type 2 diabetes. However, insurance coverage for these...